Abstracts

830 – Metabolic Complications in HIV-Exposed Uninfected Children in the Pediatric HIV AIDS Cohort Study

Background Studies have highlighted differences in metabolic health between young HIV-exposed but uninfected children (CHEU) and HIV-unexposed children. Our understanding of cardiometabolic risk factors in older CHEU is limited. Methods The PHACS Study in the Surveillance Monitoring for ART Toxicities Study (SMARTT) Study enrolled CHEU in the United States and Puerto Rico within 1 week…

291 – Impact of Vaccine-Elicited CD8+ T-Cells on SIV Dynamics

Background Enhancing immune-mediated clearance of latently infected cells is a key strategy to achieving an HIV cure. Here we evaluated CD8+ T cell responses to a potent vaccine regimen administered to rhesus macaques (RMs) prior to SIV infection or after viral suppression mediated by antiretroviral therapy (ART) to define how vaccine-elicited CD8+ T cells impact…

300 – Clinical Predictors of Nascent Broadly Neutralizing Antibody (bNAb) Responses in PLWH on ART

Background Therapeutic HIV vaccines in development aim to induce, mature and boost broadly neutralizing antibody (bnAb) responses in persons living with HIV (PLWH) on antiretroviral therapy (ART) with the potential goal of ART-free remission. Biomarkers are needed to assess such neutralizing responses. We developed and validated an assay to measure nascent bnAb activity using an…

887 – Substance Use Disorder Patterns and HIV Acquisition: Insights From Advanced Machine Learning

Background Substance use, particularly substance use disorder (SUD), is a well-documented risk factor for HIV acquisition. However, little is known about how dynamic substance use/disorder patterns, such as SUD relapse and poly-substance use over time, influence HIV acquisition.  Methods Utilizing data from the All of Us (AoU) participants enrolled from May 6, 2018, to October…

1096 – Implementing Self-Screening for Extragenital Chlamydia and Gonorrhea in Low-Resource US Settings

Background In 2021, U.S. Centers for Disease Control and Prevention expanded recommendations for rectal and pharyngeal screening for chlamydia and gonorrhea among sexual and gender minorities, adolescents and young adults. Offering self-collection improves extragenital testing uptake. However, no extragenital assays have been FDA-approved for self-collection, hindering implementation. To overcome this regulatory barrier in a low-resource…

648 – A Telehealth Intervention for Cardiovascular Risks in Veterans With HIV: A Randomized Trial

Background People with HIV (PWH) have increased cardiovascular disease (CVD) risk compared to those without. Managing modifiable risk factors such as blood pressure (BP) and lipids remains suboptimal in this population. Non-physician-led telehealth interventions have shown efficacy in optimizing CVD risk factors in general populations, but their impact in PWH is less established. The V-EXTRA-CVD…

375 – HIV-2 Translation-Competent Reservoir Cells Phenotype Is Similar Yet Different Compared to HIV-1

Background While HIV-1 reservoir has been widely studied, corresponding data on HIV-2 including reservoir size, inducibility and phenotype are still missing. In this study, we used a single-cell approach to test whether multiple parameters that were previously identified as enrichment markers for HIV-1 infection, are also associated with the inducible HIV-2 reservoir. Methods PBMCs samples…

1109 – Impact of Same-Day ART Initiation on Viral Suppression and Engagement in a Universal Care System

Background Same-day (SD) antiretroviral therapy (ART) initiation is promoted to accelerate viral suppression and reduce early disengagement from care. Evidence supporting SD still reveals a discrepancy between randomized and observational studies and primarily comes from low- and middle-income countries (LMICs) and U.S. safety-net programs. Whether SD confers benefit in high-income settings with universal, free-of-charge HIV care…

878 – HIV Molecular Epidemiology in a Declining Generalized Epidemic: A Population-Based Study in Uganda

Background In African settings with high treatment coverage and declining incidence, it is unclear whether residual infections are driven primarily by external introductions or persistent local transmission. We examined sources of new infections in a multi-subtype epidemic during a period of expanded intervention access and falling incidence. Methods We analyzed gag (p24) and env (gp41)…